• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2014 Fiscal Year Final Research Report

Ophthalmic formulation of solid nanoparticles permits the retinal therapy, and lead to the therapy in the glaucoma patient

Research Project

  • PDF
Project/Area Number 25860129
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Medical pharmacy
Research InstitutionKinki University

Principal Investigator

NAGAI Noriaki  近畿大学, 薬学部, 講師 (90411579)

Project Period (FY) 2013-04-01 – 2015-03-31
Keywordsナノ粒子 / シロスタゾール / 眼後部治療 / 網膜 / 緑内障 / 角膜透過 / 眼圧 / DDS
Outline of Final Research Achievements

We attempted to establish a new method for preparing drug solid nanoparticles, and succeeded in preparing a high quality dispersion containing cilostazol (CLZ) nanoparticles. In addition, the instillation of the ophthalmic dispersions containing CLZ nanoparticles suppresses retinal vasoconstriction in endothelin-1-injected rats. It is possible that an ocular drug delivery system using drug nanoparticles may expand their usage as therapy in the glaucoma patient.

Free Research Field

医歯薬学

URL: 

Published: 2016-06-03  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi